Today, we have the privilege of speaking with Andrew, a distinguished leader with over 15 years of international experience in marketing, commercial excellence, and business strategy. Throughout his career, he has led large teams at top pharmaceutical and medical device companies, including Novartis, Terumo, and Penumbra Inc. Andrew is a proud graduate of the IGNITE Program at Stanford Graduate School of Business and has also studied at several other prestigious international business schools. His expertise and journey in medical innovation make him a key voice in understanding the challenges and opportunities within the industry.
Andrew Ortega-Verdaguer, IntelVasc Inc.
Subscribe to Our Newsletter
Get the latest on clinical trials in Latin America — regulatory updates, market access strategies & industry trends. Delivered straight to your inbox.
Email has been submitted.
Recent Episodes
- Allison Komiyama, CEO and Founder at Bluestocking Health, LLC
- Daniel Zequeto, Founder & CEO at ODC Life Sciences
- Satabhisa Mukhopadhyay, Founder & Chief Scientist at 4D Path Inc
- Deborah Morley, Director CV Strategy and Delivery at RQM+
- Leonara vidal, Global Clinical Affairs Lead at Gentell
- Gerardo Noriega, Presiden & CEO at PercAssist, Inc
- Matt DeNardo, Chief Product Officer at Axoft
- Daniel Chen, Founder and CEO at Synthetic Design Lab
- Shareef Mahdavi, Founder at PX Movement
- See all →